Get the Stockscreener App
0.00
100.00%
-0.365
Elevation Oncology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
See More
Previous Close:
$0.365
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$21.63M
Revenue:
-
Net Income/Loss:
$-41.95M
P/E Ratio:
0.00
EPS:
-0.83
Net Cash Flow:
$-38.34M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.98
Elevation Oncology Inc Stock (ELEV) Company Profile
Name
Elevation Oncology Inc
Sector
Industry
Phone
(716) 371-1125
Address
101 FEDERAL STREET, BOSTON
Compare ELEV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELEV
Elevation Oncology Inc
|
0.00 | 21.63M | 0 | -41.95M | -38.34M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.09 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.00 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.99 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
751.33 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.92 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-21-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-21-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-25 | Initiated | William Blair | Outperform |
| May-31-24 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Mar-01-24 | Initiated | JMP Securities | Mkt Outperform |
| May-30-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Dec-23-21 | Initiated | H.C. Wainwright | Buy |
View All
Elevation Oncology Inc Stock (ELEV) Latest News
Institutional scanner results for Elevation Oncology Inc.Weekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Detecting price anomalies in Elevation Oncology Inc. with AIQuarterly Growth Report & Daily Entry Point Alerts - Newser
Elevation Oncology Inc. stock trend forecastJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Real time scanner hits for Elevation Oncology Inc. explainedGold Moves & Weekly Top Gainers Alerts - Newser
Real time pattern detection on Elevation Oncology Inc. stockJuly 2025 PostEarnings & Verified Short-Term Plans - Newser
What are Elevation Oncology Inc.’s earnings expectationsEarnings Beat & Verified Chart Pattern Signals - khodrobank.com
How to escape a deep drawdown in Elevation Oncology Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Is Elevation Oncology Inc. stock entering bullish territoryJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser
How to forecast Elevation Oncology Inc. trends using time seriesJuly 2025 Institutional & Consistent Profit Alerts - Newser
Is Elevation Oncology Inc. gaining market shareQuarterly Earnings Report & Daily Chart Pattern Signals - khodrobank.com
Is Elevation Oncology Inc. stock ready for a breakoutJuly 2025 Patterns & Community Supported Trade Ideas - Newser
Analyzing recovery setups for Elevation Oncology Inc. investorsGold Moves & High Accuracy Trade Alerts - Newser
Custom watchlist performance reports with Elevation Oncology Inc.Market Performance Summary & Growth Focused Entry Reports - Newser
Aug Intraday: Can Elevation Oncology Inc. navigate macro headwindsBond Market & Community Verified Trade Signals - khodrobank.com
Visual analytics tools that track Elevation Oncology Inc. performanceAnalyst Upgrade & Risk Controlled Daily Trade Plans - Newser
Using RSI to spot recovery in Elevation Oncology Inc.Quarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
Is Elevation Oncology Inc.’s growth already priced inQuarterly Portfolio Report & Long-Term Growth Stock Strategies - khodrobank.com
Is Elevation Oncology Inc.’s ROE strong enoughTrade Risk Summary & Growth Oriented Trade Recommendations - khodrobank.com
What data driven models say about Elevation Oncology Inc.’s futurePortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Is Elevation Oncology Inc. forming a double bottomTrade Analysis Report & Weekly Watchlist of Top Performers - khodrobank.com
Will Elevation Oncology Inc. announce a stock split2025 Analyst Calls & Fast Entry Momentum Trade Alerts - khodrobank.com
Is Elevation Oncology Inc. showing insider buyingTrade Volume Report & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Big Money Moves: Is Elevation Oncology Inc. showing insider buyingWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Can Elevation Oncology Inc. be the next market leader2025 Pullback Review & Consistent Income Trade Recommendations - khodrobank.com
Applying Wyckoff theory to Elevation Oncology Inc. stockJuly 2025 Macro Moves & Entry Point Confirmation Signals - Newser
Does Elevation Oncology Inc. have declining or rising EPSJuly 2025 Earnings & Daily Profit Focused Screening - khodrobank.com
Elevation Oncology Inc. Added to High Probability Setup List getLinesFromResByArray error: size == 0 - 강소기업뉴스
How to track smart money flows in Elevation Oncology Inc.Weekly Investment Summary & Safe Capital Growth Tips - Newser
Will Elevation Oncology Inc. continue its uptrendDollar Strength & Safe Investment Capital Preservation Plans - Newser
How sentiment analysis helps forecast Elevation Oncology Inc.Market Performance Report & Free Real-Time Volume Trigger Notifications - Newser
Elevation Oncology Inc Stock (ELEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):